Concepedia

Author

Carolien Boeckx

University of Antwerp

Also Known As

C Boeckx, Carmen Criscitiello, Carolien Boeckx, Petar Jelinic

26

Publications

1.1K

Citations

16

H-Index

24

Concepts

All Affiliations

University of AntwerpAntwerp University HospitalHistoGeneX (Belgium)
CB

About

Carolien Boeckx is an author at University of Antwerp specializing in tumor biology, extracellular matrix, and chemodynamic therapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

21

2

Medicine

1

1

21

3

Natural Sciences

1

1

61

4

Biomolecular Engineering

1

1

61

5

Cell Biology

1

1

21

Carolien Boeckx

×

11

Publications

364

Citations

11

H-Index

YearCitations

Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins

Carolien Boeckx, Ken Op de Beeck, An Wouters,

Cancer Letters

2014

61

KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis

Vanessa Deschoolmeester, Carolien Boeckx, Marc Baay,

British Journal of Cancer

2010

45

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

Carolien Boeckx, Christine Weyn, Isabelle Vanden Bempt,

BMC Research Notes

2014

39

Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and <scp>SP</scp>142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system

Kelly Schats, Emily A. Van Vré, Stefanie De Schepper,

Histopathology

2016

39

Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods

Kelly Schats, Emily A. Van Vré, Carolien Boeckx,

Archives of Pathology & Laboratory Medicine

2018

33

Expression Analysis on Archival Material Revisited

Christophe Deben, Karen Zwaenepoel, Carolien Boeckx,

Diagnostic Molecular Pathology

2013

32

Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.

Carolien Boeckx, Lina Blockx, Ken Op de Beeck,

PubMed Central

2015

30

The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors

An Wouters, Carolien Boeckx, Jan B. Vermorken,

Current Pharmaceutical Design

2012

24

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines

Carolien Boeckx, Jolien Van den Bossche, Ines De Pauw,

BMC Research Notes

2015

23

The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors

An Wouters, Carolien Boeckx, Jan B. Vermorken,

Current Pharmaceutical Design

2012

21

Page 1